113 related articles for article (PubMed ID: 7683872)
1. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Turk PS; Belliveau JF; Darnowski JW; Weinberg MC; Leenen L; Wanebo HJ
Arch Surg; 1993 May; 128(5):533-8; discussion 538-9. PubMed ID: 7683872
[TBL] [Abstract][Full Text] [Related]
2. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.
Wanebo HJ; Chung MA; Levy AI; Turk PS; Vezeridis MP; Belliveau JF
Ann Surg Oncol; 1996 May; 3(3):295-303. PubMed ID: 8726186
[TBL] [Abstract][Full Text] [Related]
3. Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum.
Wanebo HJ; DiSiena M; Begossi G; Belliveau J; Gustafson E
Ann Surg Oncol; 2008 Apr; 15(4):1107-16. PubMed ID: 18157578
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer.
Guadagni S; Fiorentini G; Palumbo G; Valenti M; Russo F; Cantore M; Deraco M; Vaglini M; Amicucci G
Arch Surg; 2001 Jan; 136(1):105-12. PubMed ID: 11146790
[TBL] [Abstract][Full Text] [Related]
5. Pelvic perfusion for locally recurrent unresectable rectal tumors.
Unal AE; Bayar S; Tez M; Gocmen E; Kocaoglu H; Akgul H
Hepatogastroenterology; 2005; 52(63):757-60. PubMed ID: 15966199
[TBL] [Abstract][Full Text] [Related]
6. [Initial locoregional chemotherapy in recurrent and locoregional advanced or inoperable stages of pelvic uterine and anorectal cancers].
Manivit P; Polo R; Tabary D; Nabet M; Polo M; Adamy M; Rubini B; Fromaget JM; Chipponi PN; Untereiner M
Bull Cancer; 1995 Jan; 82(2):137-48. PubMed ID: 10846531
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.
Guadagni S; Fiorentini G; Clementi M; Palumbo P; Mambrini A; Masedu F
Updates Surg; 2017 Sep; 69(3):403-410. PubMed ID: 28791628
[TBL] [Abstract][Full Text] [Related]
8. Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer.
Wanebo HJ; Belliveau J; Begossi G; Levy A
Colorectal Dis; 2003 Sep; 5(5):508-14. PubMed ID: 12925091
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer.
Murata S; Onozawa S; Sugihara F; Sakamoto A; Ueda T; Yamaguchi H; Yasui D; Mine T; Kumita S
Ann Surg Oncol; 2015 Nov; 22(12):3981-9. PubMed ID: 25758191
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective study.
Guadagni S; Fiorentini G; Palumbo P; Masedu F; Ricevuto E; Bruera G; Deraco M; Kusamura S; Sarti D; Fiorentini C; Gailhofer S; Clementi M
Minerva Chir; 2019 Aug; 74(4):304-312. PubMed ID: 31062943
[TBL] [Abstract][Full Text] [Related]
11. Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.
Guadagni S; Russo F; Rossi CR; Pilati PL; Miotto D; Fiorentini G; Deraco M; Santinami M; Palumbo G; Valenti M; Amicucci G
Am J Surg; 2002 Jan; 183(1):28-36. PubMed ID: 11869699
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
[TBL] [Abstract][Full Text] [Related]
13. Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study.
Guadagni S; Clementi M; Bencivenga M; Kusamura S; Fiorentini C; Masedu F
Updates Surg; 2018 Dec; 70(4):441-447. PubMed ID: 30191532
[TBL] [Abstract][Full Text] [Related]
14. [Antineoplastic perfusion with percutaneous stop-flow control in the treatment of advanced pelvic malignant neoplasms].
De Santis M; Ariosi P; Calò GF; Luppi G; Franchini M; Romagnoli R
Radiol Med; 2000; 100(1-2):56-61. PubMed ID: 11109453
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome.
Pohlen U; Rieger H; Kunick-Pohlen S; Berger G; Buhr HJ
Anticancer Res; 2007; 27(1B):667-74. PubMed ID: 17348458
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer.
Guadagni S; Aigner KR; Palumbo G; Cantore M; Fiorentini G; Pozone T; Deraco M; Clerico M; Chaudhuri PK
J Clin Pharmacol; 1998 Oct; 38(10):936-44. PubMed ID: 9807975
[TBL] [Abstract][Full Text] [Related]
17. Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer.
Vaglini M; Cascinelli F; Chiti A; Deraco M; Inglese MG; Rebuffoni G; Rizzi M; Sala B; Santoro N; Santinami M
Tumori; 1996; 82(5):459-62. PubMed ID: 9063524
[TBL] [Abstract][Full Text] [Related]
18. Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
Khawandanah M; Baxley A; Pant S
J Oncol Pharm Pract; 2015 Jun; 21(3):232-7. PubMed ID: 24627343
[TBL] [Abstract][Full Text] [Related]
19. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D'Angelo R; Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM
Eur J Surg Oncol; 2004 Aug; 30(6):663-70. PubMed ID: 15256242
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion.
Wile AG; Stemmer EA; Andrews PA; Murphy MP; Abramson IS; Howell SB
J Clin Oncol; 1985 Jun; 3(6):849-52. PubMed ID: 4009218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
